Oneness Biotech Listed in MSCI Taiwan Small Cap Index	2020-06-30
	Successful topline Phase 3 data of ON101 new drug	2020-06-15
	2020 Q2 Online Investor Conference	2020-06-10
	Leo Pharma pens Oneness Biotech, Microbio Shanghai pact for skin and asthma drug	2020-06-05
	Oneness Biotech will proceed to unblind Phase 3 data of ON101 MRCT (protocol#ON101CLCT02) according to TFDA notification letter# 1096013906	2020-05-26
	Oneness Biotech receives upfront payment of US$14.48M from LEO Pharma A/S	2020-05-14